Timing of colonoscopy in acute lower GI bleeding: a multicenter retrospective cohort study

Abstract

We aimed to determine the optimal timing of colonoscopy and factors that benefit patients who undergo early colonoscopy for acute lower GI bleeding. We identified 10,342 patients with acute hematochezia (CODE BLUE-J study) admitted to 49 hospitals in Japan. Of these, 6270 patients who underwent a colonoscopy within 120 hours were included in this study. The inverse probability of treatment weighting method was used to adjust for baseline characteristics among early (≤24 hours, n= 4133), elective (24-48 hours, n= 1137), and late (48-120 hours, n= 1000) colonoscopy. The average treatment effect was evaluated for outcomes. The primary outcome was 30-day rebleeding rate. The early group had a significantly higher rate of stigmata of recent hemorrhage (SRH) identification and a shorter length of stay than the elective and late groups. However, the 30-day rebleeding rate was significantly higher in the early group than in the elective and late groups. Interventional radiology (IVR) or surgery requirement and 30-day mortality did not significantly differ among groups. The interaction with heterogeneity of effects was observed between early and late colonoscopy and shock index (shock index<1, odds ratio [OR], 2.097; shock index≥1, OR, 1.095; P for interaction= .038) and performance status (0-2, OR, 2.481;≥3, OR, .458; P for interaction= .022) for 30-day rebleeding. Early colonoscopy had a significantly lower IVR or surgery requirement in the shock index≥1 cohort (OR, .267; 95% confidence interval, .099-.721) compared with late colonoscopy. Early colonoscopy increased the rate of SRH identification and shortened the length of stay but involved an increased risk of rebleeding and did not improve mortality and IVR or surgery requirement. Early colonoscopy particularly benefited patients with a shock index≥1 or performance status≥3 at presentation.